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1. Introduction 
Signs that may be included in the clinical presentation of congenital toxoplasmosis may be 
observed in infants without identification of Toxoplasma gondii or other intrauterine 
infection. When congenital toxoplasmosis is excluded, these case are diagnosed as having 
pseudo toxoplasmosis (Hervouet, 1961), pseudo-TORCH (toxoplasma, rubella, 
cytomegalovirus, and herpes simplex) syndrome (Baraitser et al., 1983; Burn et al., 1986; 
Cohen et al., 2012; Ishitsu et al., 1985; Knoblauch et al., 2003; Kulkarni et al., 2010; Nakamura 
et al., 2011; Reardon et al., 1994; Vivarelli et al., 2001; Watts et al., 2008; Wieczorek et al., 
1995) or congenital infection-like syndrome (Abdel-Salam & Zaki, 2009; al-Dabbous et al., 
1998; al-Gazali et al., 1999; Dale et al., 2000; Knoblauch et al., 2003; Kulkarni et al., 2010; 
Mishra et al., 2002; Mizuno et al., 2011; Slee et al.,1999).  
These signs include microcephaly (Aalfs et al., 1995; Abdel-Salam & Zaki, 2009; Abdel-
Salam et al., 1999; Abdel-Salam et al., 2000; Ahmadi & Bradfield, 2007; Aicardi & Goutières, 
1984; al-Dabbous et al., 1998; al-Gazali et al., 1999; Alzial et al., 1980; Angle et al., 1994; 
Atchaneeyasakul et al., 1998; Baraitser et al., 1983; Bogdan, 1951; Book et al., 1953; Briggs et 
al., 2008; Burn et al., 1986; Cantú et al., 1977; Casteels et al., 2001; Dale et al., 2000; Eventov-
Friedman et al., 2009; Feingold & Bartoshesky 1992; Fisch et al., 1973; Fryns et al., 1995; 
Hoyeraal et al., 1970; Hordijk et al., 1996; Hreidarsson et al., 1988; Ishitsu et al., 1985; Jarmas 
et al., 1981; Kloepfer et al., 1964; Knoblauch et al., 2003; Komai et al., 1955; Kozma et al., 
1996; Kulkarni et al., 2010; Leung, 1985; Limwongse et al., 1999; McKusick et al., 1966; 
Mishra et al., 2002; Nakamura et al., 2011; Nemos et al., 2009; Ostergaard et al., 2012; 
Pearson et al., 2008; Reardon et al., 1994; Sadler & Robinson, 1993; Simonell et al., 2002; Slee 
et al., 1999; Strauss et al., 2005; Tenconi et al., 1981; Trzupek et al., 2007; van den Bosch, 1959; 
van Genderen et al., 1997; Vasudevan et al., 2005; Vivarelli et al., 2001; Warburg & Heuer, 
1994; Wieczorek et al., 1995), intracranial calcifications (Abdel-Salam & Zaki, 2009; Aicardi & 
Goutières, 1984; al-Dabbous et al., 1998; al-Gazali et al., 1999; Asai et al., 2012; Baraitser et al., 
1983; Bogdan, 1951; Briggs et al., 2008; Burn et al., 1986; Cohen et al., 2012; Dale et al., 2000; 
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Hervouet, 1961; Ishitsu et al., 1985; Knoblauch et al., 2003; Kulkarni et al., 2010; Mishra et al., 
2002; Mizuno et al., 2011; Nakamura et al., 2011; Reardon et al., 1994; Revesz et al., 1992; Slee 
et al., 1999; Vivarelli et al., 2001; Watts et al., 2008; Wieczorek et al., 1995) and retinal changes 
(Abdel-Salam et al., 1999; Abdel-Salam et al., 2000; Ahmadi & Bradfield, 2007; Alzial et al., 
1980; Angle et al., 1994; Asai et al., 2012; Atchaneeyasakul et al., 1998; Bogdan, 1951; Burn et 
al., 1986; Cantú et al., 1977; Casteels et al., 2001; Eventov-Friedman et al., 2009; Feingold & 
Bartoshesky 1992; Fryns et al., 1995; Hervouet, 1961; Hordijk et al., 1996; King et al., 1998; 
Limwongse et al., 1999; McKusick et al., 1966; Revesz et al., 1992; Sadler & Robinson, 1993; 
Simonell et al., 2002; Strauss et al., 2005; Tenconi et al., 1981; Trzupek et al., 2007; van 
Genderen et al., 1997; Vasudevan et al., 2005; Warburg & Heuer, 1994; Watts et al., 2008). 
The majority of the cases have a family history (Abdel-Salam & Zaki, 2009; Aicardi & 
Goutières, 1984; al-Dabbous et al., 1998; al-Gazali et al., 1999; Alzial et al., 1980; 
Atchaneeyasakul et al., 1998; Baraitser et al., 1983; Bogdan, 1951; Book et al., 1953; Briggs et 
al., 2008; Burn et al., 1986; Cantú et al., 1977; Cohen et al., 2012; Dale et al., 2000; Fisch et al., 
1973; Hordijk et al., 1996; Ishitsu et al., 1985; Jarmas et al., 1981; Knoblauch et al., 2003; 
Kozma et al., 1996; Leung, 1985; Limwongse et al., 1999; McKusick et al., 1966; Reardon et 
al., 1994; Sadler & Robinson, 1993; Simonell et al., 2002; Slee et al., 1999; Trzupek et al., 2007; 
van Genderen et al., 1997; Vivarelli et al., 2001; Warburg & Heuer, 1994), and thus a genetic 
basis has been proposed.  
To diagnose the clinical entities described below, evidence of congenital infection including 
toxoplasmosis is the most important exclusion criterion. Misdiagnosis would result in 
erroneous counseling as to risk of recurrence (Aicardi et al., 2012).  
2. Clinical entities  
2.1. Aicardi syndrome  
2.1.1. Overview 
Aicardi syndrome (MIM: 304050) is a congenital disorder characterized by a triad of signs, 
including corpus callosum agenesis, severe epilepsy, and chorioretinal lacunae (Aicardi et 
al., 1965; Dennis & Bower, 1972). 
2.1.2. History 
In 1965, Aicardi et al. reported eight female infants with spasms in flexion, callosal agenesis 
and various ocular abnormalities. In 1972, Dennis & Bower also reported a female patient 
and established the Aicardi Syndrome.  
2.1.3. Genetics 
The Aicardi syndrome is believed to an X-linked dominant disorder lethal to males and the 
cases of Aicardi syndrome are female infants, and males with the XXY genotype (Hopkins et 
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al., 1979). Mutations in the CDKL5 gene on chromosome Xp22 have been found in these 
patients (Nemos et al., 2009).  
2.1.4. Differential diagnosis 
Although the Aicardi syndrome normally has a poor prognosis, there is a heterogeneity of 
clinical severity. A mild case of a chorioretinal defect and a hypoplastic disc has been 
reported (King et al., 1998). The case was misdiagnosed as having cerebral and retinal 
toxoplasmosis.  
The presence of corpus dysgenesis supports the diagnosis of Aicardi syndrome. In addition, 
the Aicardi syndrome does not cause intracranial calcifications which are likely to be 
present in cases of congenital toxoplasmosis (Table 1). Ocular abnormality is various, 






Table 1. Clinical findings of the patients affected by congnetial toxoplasmosis and the pseudo 
toxoplasmosis 
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2.2. Aicardi-Goutières Syndrome (AGS) 
2.2.1. Overview 
The AGS is a rare neurodevelopmental genetic disorder associated with intracranial 
calcification, leukocytosis in the cerebrospinal fluid (CSF), and microcephaly. (Aicardi & 
Goutières, 1984; Aicardi et al., 2012) 
2.2.2. History 
In 1984, Aicardi & Goutières reported eight infants with spasticity, acquired microcephaly, 
bilateral symmetrical calcifications in the basal ganglia and chronic CSF lymphocytosis in 
five consanguineous families. 
2.2.3. Genetics 
Approximately 90% of individuals with characteristic findings of AGS have been found to 
have mutations in the TREX1 gene on chromosome 3p21.31 (AGS1, MIM: 225750), 
RNASEH2A gene on chromosome 19p13.2 (AGS4, MIM: 610333), RNASEH2B gene on 
chromosome 13q14.3 (AGS2, MIM: 610181), RNASEH2C gene on chromosome 11q13.1 
(AGS3, MIM: 610329), and SAMHD1 gene on chromosome 20q11.23 (AGS5, MIM: 612952). 
(Aicardi et al., 2012) 
Mutations in TREX1 have also been found in some patients with systemic lupus 
erythematodes (SLE). Siblings with SLE who present with congenital infection-like 
intracranial calcification (Dale et al., 2000), may be associated with AGS. (Aicardi et al., 2012) 
It has also been suggested that the narrowly-defined pseudo-TORCH syndrome (2.6) shows 
a phenotypic overlap and that most cases of pseudo-TORCH syndrome are in fact AGS. 
(Aicardi et al., 2012) 
2.2.4. Differential diagnosis 
In case of AGS, leukocytosis in the CSF and increased concentrations of interferon-alfa (IFN-
α) in the CSF are found (Aicardi et al., 2012) and microcephaly is absent at birth (Aicardi & 
Goutières, 1984). The onset occurs at 3-6 months of age in many patients.  
Ocular structures are almost invariably normal on examination. (Aicardi et al., 2012)  
(Table 1) 
2.3. Hoyeraal-Hreidarsson syndrome (HHS) 
2.3.1. Overview 
The HHS (MIM: 300240) is a severe multisystemic disorder with pre- and postnatal growth 
retardation, progressive pancytopenia, microcephaly, and cerebellar hypoplasia. (Aalfs et 
al., 1995; Knight et al., 1999; Pearson et al., 2008)  
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2.3.2. History 
In 1970, Hoyeraal et al. reported two brothers with hypoplastic thrombocytopenia, 
microcephaly and cerebral malformations. In 1988, Hreidarsson et al. also reported an 
affected boy. In 1995, Aalfs et al. reported another male patient and proposed to use the 
eponym HHS. The first symptoms of pancytopenia did not occur before the age of five 
months and continued to deteriorate for years, despite extensive therapeutic measures. 
2.3.3. Genetics 
Mutations in the DKC1 gene on chromosome Xq28 have been found in the patients 
including the family reported by Aalfs et al. in 1995. (Knight et al., 1999) The gene is also 
responsible for X-linked dyskeratosis congenita (DKC, MIM: 305000), an inherited bone-
marrow-failure syndrome characterized by skin pigmentation, nail dystrophy and 
leucoplakia which usually develop towards the end of the first decade of life. The HHS is 
revealed to be a severe variant of DKC. (Knight et al., 1999; Pearson et al., 2008) 
2.3.4. Differential diagnosis 
The HHS is marked by severe aplastic anemia. While retinopathy can be induced by anemia, 
ocular abnormality or intracranial calcification is not usually observed in cases of HSS. 
(Table 1) 
2.4. Microcephaly, lymphedema, chorioretinal dysplasia syndrome (MLCRD) 
2.4.1. Overview 
As its name implies, the MLCRD (MIM: 152950) is characterized by a triad of signs 
including microcephaly, lymphedema, and chorioretinal dysplasia. (Angle et al., 1994; 
Casteels et al., 2001; Eventov-Friedman et al., 2009; Feingold & Bartoshesky 1992; Fryns et 
al., 1995; Limwongse et al., 1999; Ostergaard et al., 2012; Strauss et al., 2005; Vasudevan et 
al., 2005). Mental retardation is also usually present. Different combinations of these signs 
inherited in an autosomal dominant pattern have been reported (Leung, 1985; Hordijk et al., 
1996; Simonell et al., 2002). Cases with these signs have been assumed to belong to the same 
spectrum of genetic disorders.  
An autosomal recessive form of microcephaly with chorioretinopathy (McKusick et al., 
1966) has been reported and categorized as microcephaly and chorioretinopathy with or 
without mental retardation, autosomal recessive (MIM: 251270) (2.5).  
2.4.2. History 
In 1981, Tenconi et al. reported patients with microcephaly and chorioretinopathy in an 
autosomal dominant pattern, and Jarmas et al. reported two brothers with microcephaly and 
retinal folds. In 1985, Leung investigated the combination of microcephaly and lymphedema 
 
Toxoplasmosis – Recent Advances 178 
in at least 4 generations of a Chinese family. In 1992, Feingold & Bartoshesky described two 
unrelated boys with microcephaly, lymphedema and chorioretinal dysplasia and proposed 
that the combination represents a single syndrome.  
2.4.3. Genetics 
Mutations in the KIF11 gene on chromosome 10q23 have been identified in some patients 
with the MLCRD. (Ostergaard et al., 2012)  
2.4.4. Differential diagnosis 
Congenital lymphedema is confined to the dorsa of the feet (Angle et al., 1994; Casteels et 
al., 2001; Eventov-Friedman et al., 2009; Feingold & Bartoshesky 1992; Fryns et al., 1995; 
Leung, 1985; Limwongse et al., 1999; Strauss et al., 2005; Vasudevan et al., 2005) and this is 
hardly observed in cases of congenital toxoplasmosis. (Table 1) 
Intracranial calcifications, which are likely to be present in cases of congenital toxoplasmosis 
are not observed in cases of MLCRD. (Table 1) 
2.5. Microcephaly and chorioretinopathy with or without mental retardation, 
autosomal recessive 
2.5.1. Overview 
While the combination of microcephaly and chorioretinopathy with or without mental 
retardation can be caused by heterozygous mutation in the KIF11 gene known as MLCRD 
(MIM: 152950) (2.4), autosomal recessive inheritance has also been suggested in familial 
cases (McKusick et al., 1966). A discovery of causative homozygous mutation (Puffenberger 
et al., 2012) has proved the independent entity, microcephaly and chorioretinopathy with or 
without mental retardation, autosomal recessive (MIM: 251270).  
2.5.2. History 
The role of consanguinity in congenital microcephaly was repeatedly reported (Kloepfer et 
al., 1964; Komai et al., 1955; van den Bosch, 1959). In 1966, McKusick et al. described eight 
individuals of microcephaly in two sibships of an imbred group. All of them had 
pigmentary abnormality of the fundus with mental retardation.  
2.5.3. Genetics 
A homozygous mutation in the TUBGCP6 gene on chromosome 22q13.33 was found in four 
cases reported by McKusick et al. in 1966. (Puffenberger et al., 2012)  
2.5.4. Differential diagnosis 
Microcephaly and chorioretinopathy with or without mental retardation, autosomal 
recessive produces the symptoms similar to those of the MLCRD (MIM: 152950) spectrum 
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(2.4). Intracranial calcifications are not observed as in MLCRD. (Table 1) Lymphedema is 
considered to be pathognomonic for the MLCRD, has not been reported in cases of 
Microcephaly and chorioretinopathy with or without mental retardation, autosomal 
recessive. (Table 1) 
2.6 Pseudo-TORCH syndrome  
(narrowly-defined) 
2.6.1. Overview 
Narrowly-defined pseudo-TORCH syndrome (al-Dabbous et al., 1998; Baraitser et al., 1983; 
Briggs et al., 2008; Burn et al., 1986; Cohen et al., 2012; Ishitsu et al., 1985; Knoblauch et al., 
2003; Kulkarni et al., 2010; Nakamura et al., 2011; Reardon et al., 1994; Vivarelli et al., 2001; 
Watts et al., 2008; Wieczorek et al. 1995), also called Baraitser-Reardon syndrome (Vivarelli 
et al., 2001), or band-like calcification with simplified gyration and polymicrogyria 
(BLCPMG; MIM: 251290) (Abdel-Salam & Zaki, 2009; Briggs et al., 2008; O'Driscoll et al., 
2010), is associated with microcephaly and intracranial calcifications mimicking congenital 
toxoplasmosis in the absence of infection.  
2.6.2. History 
In 1983, Baraitser et al. reported two brothers with microcephaly and intracranial 
calcifications. The bilateral symmetrical calcification was in white matter and thalamus. In 
1994, Reardon et al. reported nine patients from four families with microcephaly, 
intracranial calcifications and CNS disease and described them as "congenital intrauterine 
infection-like syndrome".  
In 2001, Vivarelli et al. reported five patients in three families and proposed to use  
the eponym, Baraitser-Reardon syndrome. In 2008, Briggs et al. also reported five  
patients in three families with a pattern of BLCPMG as a distinct "pseudo-TORCH" 
phenotype. 
2.6.3. Genetics 
Mutations in the OCLN gene on chromosome 5q13.2 have been found in a part of affected 
individuals, categorized as BLCPMG. (O'Driscoll et al., 2010) A part of the cases of the 
pseudo-TORCH syndrome without the OCLN mutation may in fact be cases of Aicardi-
Goutières Syndrome (2.2). (Aicardi et al., 2012) 
2.6.4. Differential diagnosis 
As some cases of pseudo-TORCH syndrome are thought to be in fact AGS (Aicardi  
et al., 2012), there is a phenotype overlap between pseudo-TORCH syndrome and AGS  
(2.2).  
Ocular changes are not reported with pseudo-TORCH syndrome / AGS. (Table 1) 
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2.7. Revesz syndrome 
2.7.1. Overview 
Revesz syndrome (MIM: 268130), also known as cerebroretinal microangiopathy with 
calcifications and cysts (CRMCC) is a rare and fatal disorder, characterized by intrauterine 
growth retardation, bilateral exudative retinopathy, intracranial calcification and cysts. (Asai 
et al., 2012; Revesz et al. 1992; Savage et al., 2008) 
2.7.2. History 
In 1992, Revesz et al. reported a 6-month old boy presenting with bilateral leucocoria. The 
retinal appearance resembled Coat's disease. Widespread grey and white matter 
calcification in the brain and severe aplastic anemia were also noted. His platelet count 
eventually became impossible to control and the patient died at 19 months of age. In 1994, 
Kajtár & Méhes reported the second case, a 2-year old girl with thrombocytopenic purpura 
and bilateral progressive Coats’-like retinopathy.  
2.7.3. Genetics 
A heterozygous mutation in the gene encoding TRF1-interacting nuclear factor-2 (TINF2) on 
chromosome 14q12 has been found in a case of Revesz syndrome. (Savage et al., 2008) 
Another heterozygous truncating mutation in the TINF2 gene has been identified in a case. 
(Sasa et al., 2012) TINF2 is a component of the shelterin telomere protection complex, TINF2 
mutations result in very short telomeres.  
An inherited bone marrow failure syndrome, dyskeratosis congenital-3 (MIM: 613990) is 
also caused by the mutations in the TINF2 mutations.  
2.7.4. Differential diagnosis 
While Revesz syndrome marked by the severe aplastic anemia is related to HHS (2.3), 
Revesz syndrome causes Coats’-like retinopathy and intracranial calcification. A case 
reported as "congenital infection-like syndrome with intracranial calcification" (Mizuno et 
al., 2011) may be a case of Revesz syndrome. (Asai et al., 2012) 
Coats’-like retinopathy is exudative, easily distinguishable from chorioretinal lacunae or 
dysplasia on ophthalmoscopy. (Table 1) 
3. Pseudo-pseudo toxoplasmosis 
3.1. Background 
Even though clinical differential diagnosis summarized in Table 1 can be helpful, there are 
exceptions. A case of congenital toxoplasmosis can have the look of one of pseudo 
toxoplasmosis entities. A serological investigation for toxoplasmosis also has its indications 
and limitations. (Johnson et al., 1993). 
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3.2. Case report 
A male infant was delivered by Cesarean section at 37 weeks of gestation. (Ozeki et al., 2010) 
There was no family history for microcephaly, retinitis pigmentosa or consanguinity. The 
mother was type 1 diabetic and had once experienced an intrauterine fetal death. At 20 
weeks pregnant, microcephaly had been detected by ultrasonography. Toxoplasmosis had 
been suspected, but the treatment was withheld because of only a slightly elevated maternal 
Toxoplasma specific immunoglobulin M (IgM) antibody, 1.4 index by enzyme linked 
immnosorbent assay (ELISA) and a borderline IgG avidity index, 50% at 28 weeks pregnant.  
The infant weighing 2,858 g with Apgar score 9/10, respectively, had microcephaly, marked 
lymphoedema of dorsum of both feet and chorioretinal dysplasia in the both eyes (Figure 1). The 
electroretinogram was nearly nonrecordable. A computed tomography (CT) scan was negative 
for brain calcifications or hydrocephalus. Hepatic calcifications, splenomegaly, and ascites were 
not noted.  Toxoplasma IgM (ELISA) was negative (0.1 index) while IgG was positive (70 index).  
Toxoplasma gondii DNA was detected in the serum by polymerase chain reaction (PCR) 
(Figure 1(d)) to confirm the diagnosis of congenital toxoplasmosis. 
 
Figure 1.  
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3.3. Comment 
The newborn presented with the complete triad of the MLCRD (2.4), i.e., microcephaly, 
lymphedema and chorioretinal dysplasia. (Table 1) He had apparent dorsal lymphedema 
that is hardly observed with toxoplasmosis. Brain calcifications, hydrocephalus, ascites or 
splenomegaly, that are more likely present in cases of congenital toxoplasmosis, could not 
be found. Moreover, Toxoplasma IgM was negative.  
The present case indicates that suspected cases of congenital toxoplasmosis or pseudo 
toxoplasmosis should be examined for Toxoplasma DNA by PCR. (Ozeki et al., 2010) 
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